Kanabo Group PLC

KNB

Company Profile

  • Business description

    Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment, which derives key revenue, includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom and Israel.

  • Contact

    137-139 Brent Street
    Churchill House
    LondonNW4 4DJ
    GBR

    T: +44 2074690930

    E: [email protected]

    https://www.kanabogroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Care Facilities

    Fiscal Year End

    31 December 2025

    Employees

    16

Stocks News & Analysis

stocks

Fair value downgraded for ASX heavyweight

Our capital allocation rating was also lowered due to balance sheet weakness.
stocks

ChatGPT enters the retail space and one company surges

Investors cheer the ability to purchase directly from ChatGPT.
stocks

Alibaba fair value increases by 49%

Stronger-than-expected AI demand internationally and domestically.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,104.7016.80-0.18%
CAC 407,895.9415.070.19%
DAX 4023,880.72135.660.57%
Dow JONES (US)46,397.8981.820.18%
FTSE 1009,350.4350.590.54%
HKSE26,855.56232.680.87%
NASDAQ22,660.0168.860.30%
Nikkei 22544,479.09453.54-1.01%
NZX 50 Index13,374.2281.860.62%
S&P 5006,688.4627.250.41%
S&P/ASX 2008,813.5019.90-0.23%
SSE Composite Index3,882.7820.250.52%

Market Movers